![Christopher Missling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Missling
Keine laufenden Positionen mehr
Vermögen: 4 Mio $ am 30.06.2026
Profil
Christopher U.
Missling worked at Anavex Life Sciences Corp.
from 2013 to 2026 as President, CEO, Secretary, and Director.
Previous roles include Chief Financial Officer at ImmunoGen, Inc., CFO and Senior Vice President-Strategic Operations at Curis, Inc., Head of Financial Planning at Aventis, Inc., and Head of Healthcare Investment Banking at Brimberg & Co. Education includes graduate and doctorate degrees from Ludwig-Maximilians-Universität München, an MBA from WHU-Otto Beisheim School of Management, and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.01.2026 | 1.510.165 ( 1,63 % ) | 4 Mio $ | 30.06.2026 |
Ehemalige bekannte Positionen von Christopher Missling
| Unternehmen | Position | Ende |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Vorstandsvorsitzender | 30.04.2026 |
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Corporate Officer/Principal | - |
Brimberg & Co.
 Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
| IMMUNOGEN, INC. | Finanzdirektor/CFO | - |
| CURIS, INC. | Finanzdirektor/CFO | - |
Ausbildung von Christopher Missling
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WHU-Otto Beisheim School of Management
 WHU-Otto Beisheim School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
 Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
